Eccovia Solutions brings care coordination to Los Angeles health services

The Los Angeles County Department of Health Services has selected Eccovia Solutions, a provider of healthcare coordination platforms, to develop a care coordination platform for the county’s 1115 Waiver Whole-Person Care (WPC) pilot program.

The ClientTrack Care Coordination platform will be used to bring primary care and community resources together, aiming to improve the sharing of patient information. The platform allows for collaboration between many different entities as well as data visualization to measure effectiveness.

The WPC program plans on developing a health system focusing on 50,000 of the most in-need people in the largest county in America. The program plans on expanding healthcare at lower costs with 11 programs to address an array of needs:

The 11 programs include:

  • Homeless care support services
  • Tenancy support services
  • Recuperative care
  • Sobering center
  • Benefits advocacy
  • Re-entry enhanced care coordination
  • Community-based re-entry
  • Intensive service recipients
  • Residential and bridging care
  • Substance abuse disorder engagement, navigation and support
  • Transitions of care

“This care coordination platform will provide the technology infrastructure for Whole Person Care-LA and enable our teams to connect the most vulnerable Los Angeles county residents to services,” said Clemens Hong, MD, MPH, director of Whole Person Care Los Angeles. “This will improve the overall well-being of these individuals and decrease the use of high-cost services.”

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.